Broccoli Microgreen Metabotyping in Obese Breast Cancer Survivors

This clinical trial is focused on exploring the potential health benefits of broccoli microgreens for obese breast cancer survivors. The study involves participants from the University of Maryland Medical Center in Baltimore who will incorporate a specific serving of raw broccoli microgreens into their daily meals for two weeks. The researchers aim to determine if this addition is practical for the participants and whether it can positively affect their metabolism and gut health. The insights gained from this study could lead to new strategies to improve the management of obesity and metabolic disorders in breast cancer survivors, complementing traditional care and supporting long-term health. Participants in the study will consume broccoli microgreens as part of their regular diet and undergo assessments to track changes in their metabolic parameters and gut health. To measure the effects, the study will collect biological samples such as blood and fecal samples, and participants will also complete questionnaires at the beginning and end of the two-week period. This information will help evaluate the feasibility of the intervention and any potential health benefits, providing valuable data on how broccoli microgreens might assist in managing obesity-related issues for breast cancer survivors.